Professor, Department of Pathology and Laboratory Medicine, University of British Columbia, Canada
Cure Alzheimer’s Fund Research Leadership Group
Cheryl Wellington’s research program encompasses the genetic and environmental risk factors that affect dementia, including apolipoprotein E (APOE) metabolism, history of traumatic brain injury (TBI) and cerebrovascular dysfunction.
Her research projects include drug discovery efforts to increase apolipoprotein function in the brain for application to both Alzheimer’s disease and TBI, understanding the relationships between TBI and dementia, and innovative tissue engineering approaches to investigate cerebrovascular function in health and disease. One of her grants with Cure Alzheimer’s Fund is to engineer cerebral vessels to explore how the APOE protein affects cerebrovascular properties related to Alzheimer’s disease.
“I want to discover and validate better ways to diagnose and treat brain disorders, especially Alzheimer’s disease and traumatic brain injury.”